SRES-744-119
Referred to the Committee on the Judiciary. (text: CR S2420)
What it does
This resolution would designate May 2026 as "Osteoporosis Prevention and Awareness Month." It would affirm the Senate's commitment to raising public and professional awareness about bone health and osteoporotic fracture prevention. The resolution would also commend states, localities, organizations, researchers, volunteers, and caregivers working on osteoporosis awareness and care. It does not create any new programs, mandate any actions, or appropriate any funds.
Who benefits
The approximately 54 million Americans with osteoporosis or low bone mass may benefit from increased public awareness. Health advocacy organizations focused on bone health and osteoporosis may gain visibility. Researchers in the field may benefit from heightened public attention. Older adults — particularly women over 50, who face a 1-in-2 lifetime fracture risk — stand to benefit most from any resulting increase in screening or treatment uptake.
Who is hurt
No group faces a direct material harm from this resolution. Because it is purely symbolic and carries no legal or fiscal force, there are no identifiable parties who bear costs or lose rights as a result of its passage.
Supporters argue
Supporters argue that osteoporosis is a severely underdiagnosed and undertreated condition — only 8% of patients are screened within six months of a fracture, and only about 20% of hip fracture patients receive proven preventive medication. They contend that a formal Senate designation raises the profile of a "silent disease" that costs Medicare an estimated $57 billion annually in fracture-related expenses, helping prompt both patients and clinicians to act on prevention and early detection.
Opponents argue
Opponents might argue that symbolic resolutions consume limited legislative floor time and committee resources without producing measurable health outcomes, since the designation carries no funding, no mandates, and no enforcement mechanism. They could contend that the Senate's attention would be better directed toward substantive legislation — such as expanding Medicare coverage for bone density screenings or funding fracture liaison services — that would directly address the low screening and treatment rates the resolution itself cites.